Published in Ann Surg Treat Res on March 26, 2015
Report of incidence and mortality in China cancer registries, 2009. Chin J Cancer Res (2013) 2.88
Increased cancer risk after liver transplantation: a population-based study. J Hepatol (2001) 2.25
The current management of hepatoblastoma: a combination of chemotherapy, conventional resection, and liver transplantation. J Pediatr (2005) 1.81
Post-transplant malignancy: the role of immunosuppression. Drug Saf (2000) 1.53
Skin cancer and other cutaneous disorders in liver transplant recipients. Acta Derm Venereol (2012) 1.41
Posttransplant malignancies in solid organ adult recipients: an analysis of the U.S. National Transplant Database. Transplantation (2012) 1.31
Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation (1998) 1.28
Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl (1998) 1.13
Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation (2000) 1.12
Late graft loss or death in pediatric liver transplantation: an analysis of the SPLIT database. Am J Transplant (2007) 1.03
De novo malignancies after liver transplantation: incidence comparison with the Korean cancer registry. Transplant Proc (2012) 1.01
Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment. Transplantation (2003) 0.91
Organ transplant recipients and skin cancer: assessment of risk factors with focus on sun exposure. Br J Dermatol (2009) 0.90
Evolution and management of de novo neoplasm post-liver transplantation: a 20-year experience from a single European centre. Hepatol Int (2010) 0.86
Cancers of new appearance in liver transplant recipients: incidence and evolution. Transplant Proc (2006) 0.82
Minimizing the risk of posttransplant malignancy. Transplant Proc (2008) 0.81
Skin cancers after liver transplantation: what to do? J Hepatol (2005) 0.81
De novo posttransplantation nonlymphoproliferative malignancies in liver transplant recipients. Transplant Proc (2007) 0.80
A multicenter experience with generic mycophenolate mofetil conversion in stable liver transplant recipients. Ann Surg Treat Res (2014) 0.80
The paracholedochal vein: a feasible option as portal inflow in living donor liver transplantation. Ann Surg Treat Res (2014) 0.78
De novo malignancies after liver transplantation: a single-center experience. Ann Saudi Med (2012) 0.78
De novo cancer after orthotopic liver transplantation. Transplant Proc (1998) 0.78
In vivo photoacoustic tomography of EGFR overexpressed in hepatocellular carcinoma mouse xenograft. Photoacoustics (2016) 0.75